There was a marked depression of urinary markers of bone resorption (pyridinoline and deoxypyridinoline) in patients treated with Bondronat that was statistically significant compared to placebo.
Der påvistes en tydelig nedsættelse af urinmarkørerne for knogleresorption (pyridinolin og deoxypyridinolin) hos patienterne behandlet med Bondronat, hvilket var statistisk signifikant i forhold til placebo.